Chapter 15: Lung: Chronic Diffuse Interstitial (Restrictive) Diseases Flashcards
What is Chronic interstitial disease?
Chronic interstitial diseases are a heterogeneous group of disorders characterized
predominantly by inflammation and fibrosis of the pulmonary connective tissue, principally the
most peripheral and delicate interstitiumin thealveolar walls.
Many of the entities are of
unknown cause and pathogenesis,some have anintra-alveolar as well as an interstitial
component,and there isfrequent overlap in histologic features among the different conditions.
These disorders account for about 15% of noninfectious diseases seen by pulmonary
physicians.
In general, the clinical and pulmonary functional changes of Chronic Diffuse Interstitial (Restrictive) Diseases are:
those of restrictive lung disease
(see the earlier discussion of obstructive versus restrictive pulmonary diseases).
Patients have
dyspnea, tachypnea, end-inspiratory crackles, and eventual cyanosis, without wheezing or
other evidence of airway obstruction.
What is the classic Chronic Diffuse Interstitial (Restrictive) Diseases?
The classic physiologic features are reductions in carbon
monoxide diffusing capacity, lung volume, and compliance.
Why is Chronic Diffuse Interstitial (Restrictive) Diseases called infiltritative?
Chest radiographs show bilateral
infiltrative lesions in the form of small nodules, irregular lines,orground-glass shadows, hence
the term infiltrative.
What are the circumstances in patients with Chronic infitritative ( restrictive) disease?
Eventually, secondary pulmonary hypertension and right-sided heart failure
with cor pulmonale may result.
Although the entities can often be distinguished in the early
stages.
Why is hard to differentitate the advanced forms of Chronic Infiltrative ( Restrictive) Disease?
the advanced forms are hard to differentiate because they result in scarring and gross
destruction of the lung, often referred to as end-stage lung or honeycomb lung
How do you categorized Chronic infiltrative ( restrictive) disease?
Diffuse
restrictive diseases are categorized based on histology and clinical features
TABLE 15-5 – Major Categories of Chronic Interstitial Lung Disease
- FIBROSING
- GRANULOMATOUS
- EOSINOPHILIC
- SMOKING RELATED
TABLE 15-5 – Major Categories of Chronic Interstitial Lung Disease
FIBROSING
- Usual interstitial pneumonia (idiopathic pulmonary fibrosis)
- Nonspecific interstitial pneumonia
- Cryptogenic organizing pneumonia
- Associated with connective tissue diseases
- Pneumoconiosis
- Drug reactions
- Radiation pneumonitis
TABLE 15-5 – Major Categories of Chronic Interstitial Lung Disease
GRANULOMATOUS
- Sarcoidosis
- Hypersensitivity pneumonitis
TABLE 15-5 – Major Categories of Chronic Interstitial Lung Disease
SMOKING RELATED
- Desquamative interstitial pneumonia
- Respiratory bronchiolitis-associated interstitial lung disease
What is Idiopathic Pulmonary Fibrosis?
The term idiopathic pulmonary fibrosis (IPF) refers to a clinicopathologic syndrome with
characteristic radiologic, pathologic, and clinical features.
**In Europe the term cryptogenic
fibrosing alveolitis is more popular
What is the other name of Idiopathic Pulmonary Fibrosis ?
cryptogenic fibrosing alveolitis
The histologic pattern of fibrosis is referred to as __________, which is required for the diagnosis of IPF but can also be seen in
other diseases,notably connective tissue diseases, chronic hypersensitivity pneumonia, and
asbestosis.
usual interstitial pneumonia (UIP)
The International Multidisciplinary Consensus Classification is an excellent
reference for definitions and understanding of idiopathic interstitial pneumonias
What is the pathogenesis of IPF?
The earlier view was that IPF is initiated by an
unidentified insultthatgives rise to chronic inflammation resulting in fibrosis.
The dismal failure
of potent anti-inflammatory therapy in altering the course of the disease did not support this
view.
The current concept is that IPF is caused by “repeated cycles” of epithelial
activation/injury by some unidentified agent.
There is inflammation and induction of TH2 type T
cell response characterized by the presence of eosinophils, mast cells, IL-4 and IL-13 in the
lesions.
But the significance of this inflammatory response is unknown.
Abnormal epithelial
repair at these sites gives rise to exuberant fibroblastic/myofibroblastic proliferation, leading to
the “fibroblastic foci” that are so characteristic of IPF ( Fig. 15-13 ).
The circuits that drive such
aberrant epithelial repair are not fully understood, but all evidence points to TGF-β1 as the
driver of the process.
TGF-β1 is known to be fibrogenic and is released from injured type I
alveolar epithelial cells ( Fig. 15-13 ).
It favors the transformation of fibroblasts into
myofibroblasts and deposition of collagen and other extracellular matrix molecules.
What are fibroblastic foci that are so characteristic of IPF?
Abnormal epithelial
repairat these sites gives rise toexuberant fibroblastic/myofibroblastic proliferation, leading to
the “fibroblastic foci” that are so characteristic of IPF ( Fig. 15-13 ).
In IPF, though the aberrant epithelial repair isnt fully understood, where does all the evidence of pathology point to?
The circuits that drive such
aberrant epithelial repair are not fully understood, but all evidence points to TGF-β1 as the
driver of the process.
What is TGF- B1?
TGF-β1 is known to be fibrogenic and is released from injured type I alveolar epithelial cells ( Fig. 15-13 ).
- *It favors the transformation of fibroblasts** into
- *myofibroblasts and deposition of collagen** and other extracellular matrix molecules.

FIGURE 15-13 Schematic representation of current understanding of the pathogenesis of
idiopathic pulmonary fibrosis.
What are the two molecules regulated by TGF-β1?
- telomerase activity
- caveolin-1
What is the relation of telomerase shortening in IPF?
The concept that there is an intrinsic abnormality of tissue repair in IPF is supported by the
finding that some patients with familial pulmonary fibrosis have mutations that shorten
telomeres.
Recall that telomeres control cell replications (see Chapters 1 and 7 and with
- *shortening of telomeres alveolar epithelial cells undergo rapid senescence and
apoptosis. **[56,] [57]
Interestingly, TGF-β1 negatively regulates telomerase activity , thus
facilitating epithelial cell apoptosis and the cycle of death and repair.
What does caveolin- 1 does?
Another molecule
regulated by TGF-β1 is caveolin-1, the predominant structural protein of caveolae, flaskshaped
invaginations of the plasma membrane present in many terminally differentiated cells.
Caveolin-1 acts as an endogenous inhibitor of pulmonary fibrosis by limiting TGF-β1–induced
production of extracellular matrix and restoring alveolar epithelial repair processes.
Caveolin-1
is decreased in epithelial cells and fibroblasts of IPF patients, and overexpression of caveolin-1
in a mouse model limits fibrosis. [59]
Such down-regulation may be mediated by the ability of TGF-β1 to attenuate the expression of caveolin-1 in fibroblasts.
Thus, it seems that TGF-β1
has its fingerprints on multiple pathways that regulate pulmonary fibrosis.
Therapeutics directed
toward neutralizing TGF-β1, enhancing telomerase activity or delaying telomere shortening, or
augmenting caveolin-1 may lead to novel treatments for IPF in the future.
What is the macroscopic appearance of IPF?
Grossly, the pleural surfaces of the lung are cobblestoned as a result of the
retraction of scars along the interlobular septa.
The cut surface shows fibrosis (firm, rubbery
white areas)of thelung parenchyma with lower-lobe predominanceanda distinctive
distribution in the subpleural regions and along the interlobular septa.











